Actively Recruiting
Reliability and Validity of the Turkish Version of the Behavioral Indicators of Pain Scale in Mechanically Ventilated Intensive Care Unit Patients
Led by Saglik Bilimleri Universitesi · Updated on 2026-03-16
50
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
Sponsors
S
Saglik Bilimleri Universitesi
Lead Sponsor
F
Fenerbahce University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the Turkish validity and reliability of the Behavioral Indicators of Pain Scale (ESCID) in patients who are mechanically ventilated in intensive care units (ICUs) and unable to communicate verbally. Pain in ICU patients, especially those on mechanical ventilation, is often overlooked despite being linked to agitation and delirium. The study aims to translate, culturally adapt, and test the ESCID scale for assessing pain in this patient group. The ESCID scale will be applied to a group of 50 intubated ICU patients who cannot verbally express their pain. This scale uses behavioral indicators to evaluate pain levels. The study focuses on assessing how well the Turkish version of the ESCID scale works and how reliable it is for use with critically ill patients receiving mechanical ventilation. Participants will be monitored over a five-month period during which the ESCID scale will be used to assess their pain. Researchers will collect data on pain behaviors, and the study will measure the scale's accuracy and consistency in this group. The results will help improve pain assessment and management for ICU patients who cannot communicate their pain effectively.
CONDITIONS
Brief Title
Turkish Validity and Reliability of the Behavioral Indicators of Pain Scale(ESCID)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 18 years and older
- Patients who are intubated, receiving mechanical ventilation, and unable to communicate verbally (Glasgow Coma Scale score <14)
- Patients hospitalized in the intensive care unit for at least 24 hours
You will not qualify if you...
- Presence of postoperative complications
- Hemodynamic instability
- History of diagnosed cognitive or psychiatric disorders
- History of epilepsy or use of neuromuscular blocking agents
- History of spinal cord injury affecting motor function of all four extremities
- Richmond Agitation-Sedation Scale (RASS) score of -5 (unresponsive)
- Cases with suspected brain death
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 months
Participants undergo assessment using the ESCID scale to evaluate pain through behavioral indicators.
Multiple assessments during ICU stay
Duration - Up to 5 months
Participants are observed to validate and monitor the behavioral indicators of pain over time.
Follow-up assessments as needed
Trial Site Locations
Total: 1 location
1
Goztepe Prof Dr Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
M
Mehmet Burak Uyaroğlu, Asst Prof
E
Esra Pehlivan, Prof Dr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here